31 octobre 2017

XENTECH – nouveau membre

XenTech, a Biotech Company developing a pre-clinical platform for translational research in oncology based on a large panel of PDX models. XenTech has its own R&D programs and makes its platform available to Pharmaceutical Companies & Academic Institutions through service and research collaborations.

En savoir plus